Carnegie Investment Counsel’s Astera Labs ALAB Stock Holding History
Bought
Maintained
Sold
Other funds holding ALAB
Carnegie Investment Counsel's ALAB Position: Q2 2026 in Review
Carnegie Investment Counsel reduced its Astera Labs (ALAB) stake by 99% in Q2 2026, selling an estimated $20M and leaving 722 shares worth $349K. The position accounts for 0.01% of the portfolio, ranked #458.
Carnegie Investment Counsel first reported a position in ALAB in Q4 2025 and has held it in 3 quarters since. The position peaked at $10M in Q4 2025. 988 funds tracked by Wall St. Rank hold ALAB as of Q2 2026.
- Carnegie Investment Counsel held 722 shares of Astera Labs worth $349K as of Q2 2026.
- Carnegie Investment Counsel sold 75,397 Astera Labs shares in Q2 2026, an estimated $20M.
- Astera Labs made up 0.01% of Carnegie Investment Counsel's portfolio in Q2 2026, its #458 holding.
- Carnegie Investment Counsel first reported a position in Astera Labs in Q4 2025 and has held it in 3 quarters since.
- Carnegie Investment Counsel's Astera Labs position peaked at $10M in Q4 2025.
- 988 funds tracked by Wall St. Rank held Astera Labs as of Q2 2026.
Based on Carnegie Investment Counsel's 13F filing for Q2 2026, filed 30 Jul 2026.